Krishna Institute of Medical Sciences543308Stake acquisition deal
KIMS board approves acquiring up to 22% stake in Splendid Hospitals (Kompally) for up to Rs. 40.00 Cr via primary infusion
- Stake Acquired
- Up to 22% of the equity shares of Rs. 10 each of the target, by way of primary infusion
- Consideration
- Cash. Aggregate consideration of up to Rs. 40.00 Cr
- Completion Timeline
- Completion on or before 31.03.2027
- Target
- Splendid Hospitals Private Limited (Kompally)
- Transaction
- Acquisition of equity stake by way of primary infusion
KIMS board approves acquiring up to 22% stake in Splendid Hospitals (Kompally) for up to Rs. 40.00 Cr via primary infusion.
Target date of incorporation
Valuation report date
Board approval
Scheduled completion on or before
Also from Krishna Institute of Medical Sciences
Technical analyst recommended exiting Kims on bounce after stock fell 10% in four sessions
7 Oct 2026
Target-entity net worth, turnover and PAT figures corrected in exchange update
7 Oct 2026
Kims to acquire 22% stake in Splendid Hospitals for up to Rs 40 crore via primary infusion
7 Oct 2026
More numbers
- Aggregate consideration (cash, up to)Rs. 40.00 Cr
- Equity stake acquired (up to)22%
- Face value per equity shareRs. 10
- Target turnover FY 2025-261.39 (Rs. in Crore)
- Target PAT FY 2025-26-8.92 (Rs. in Crore)
- Target networth38.69 (Rs. in Crore)
- Target turnover FY250.30 (Amount in Crores)
- Target turnover FY240.00 (Amount in Crores)
- Expandable bed capacity225+
Source: BSE · 6 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.